Glasgow Prognostic Score is a Predictor of Perioperative and Long-term Outcome in Patients with only Surgically Treated Esophageal Cancer
- 28 October 2010
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 18 (4) , 1130-1138
Abstract
Systemic inflammation (SI) plays a pivotal role in cancer. C-reactive protein (CRP) and albumin as parameters of SI form the Glasgow Prognostic Score (GPS). The purpose of the study was to evaluate the potential prognostic role of GPS in a homogeneous population of esophageal cancer (EC) patients undergoing only resection. GPS was evaluated on the basis of admission blood sample taken before surgery. Patients with a CRP < 10 mg/L and albumin > 35 g/L were allocated to GPS0 group. If only CRP was increased or albumin decreased patients were allocated to the GPS1 and patients in whom CRP was ≥10 mg/L and albumin level ≤35 g/L were classified as GPS2. GPS was correlated to clinicopathological parameters and clinical outcome. Increasing GPS significantly correlated with more aggressive tumor biology in terms of tumor size (P < 0.001), presence of regional (P = 0.01) and nonregional lymph node metastasis (P = 0.02), and higher tumor recurrence rate (P < 0.001). Furthermore, GPS was identified as an independent prognosticator of perioperative morbidity (odds ratio 1.9; P = 0.03). In addition, a gradual decrease in disease-free and overall survival was evident between the three GPS subgroups. Survival differences between the GPS groups remained apparent even after stratification of the study population to underlying tumor type and nodal status. GPS was identified as a strong prognosticator of tumor recurrence (hazard ratio 2.5; P < 0.001) and survival (hazard ratio 3.0; P < 0.001) in EC. GPS represents a strong prognosticator of perioperative morbidity and long-term outcome in resected EC patients without neoadjuvant or adjuvant treatment.Keywords
This publication has 50 references indexed in Scilit:
- Inflammation and Colon CancerGastroenterology, 2010
- Exploring a cancer biomarker: the example of C-reactive protein.JNCI: Journal of the National Cancer Institute, 2010
- The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancerBritish Journal of Cancer, 2009
- C-Reactive Protein and Risk of Breast CancerJNCI: Journal of the National Cancer Institute, 2007
- Undernutrition is predictive of early mortality after palliative self-expanding metal stent insertion in patients with inoperable or recurrent esophageal cancerGastrointestinal Endoscopy, 2006
- The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancerBritish Journal of Cancer, 2002
- Prognostic Factors in Advanced Gastrointestinal Cancer Patients With Weight LossNutrition and Cancer, 2000
- Longitudinal Study of Weight, Appetite, Performance Status, and Inflammation in Advanced Gastrointestinal CancerNutrition and Cancer, 1999
- Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal CancerNew England Journal of Medicine, 1998
- Protein-calorie undernutrition in hospitalized cancer patientsThe American Journal of Medicine, 1980